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Background: Multiple laboratories now offer clinical whole genome sequencing (WGS). We anticipate WGS becoming
routinely used in research and clinical practice. Many institutions are exploring how best to educate geneticists and
other professionals about WGS. Providing students in WGS courses with the option to analyze their own genome
sequence is one strategy that might enhance students’ engagement and motivation to learn about personal genomics.
However, if this option is presented to students, it is vital they make informed decisions, do not feel pressured into
analyzing their own genomes by their course directors or peers, and feel free to analyze a third-party genome if they
prefer. We therefore developed a 26-hour introductory genomics course in part to help students make informed
decisions about whether to receive personal WGS data in a subsequent advanced genomics course. In the advanced
course, they had the option to receive their own personal genome data, or an anonymous genome, at no financial
cost to them. Our primary aims were to examine whether students made informed decisions regarding analyzing
their personal genomes, and whether there was evidence that the introductory course enabled the students to make
a more informed decision.
Methods: This was a longitudinal cohort study in which students (N = 19) completed questionnaires assessing their
intentions, informed decision-making, attitudes and knowledge before (T1) and after (T2) the introductory course,
and before the advanced course (T3). Informed decision-making was assessed using the Decisional Conflict Scale.
Results: At the start of the introductory course (T1), most (17/19) students intended to receive their personal WGS
data in the subsequent course, but many expressed conflict around this decision. Decisional conflict decreased after
the introductory course (T2) indicating there was an increase in informed decision-making, and did not change
before the advanced course (T3). This suggests that it was the introductory course content rather than simply
time passing that had the effect. In the advanced course, all (19/19) students opted to receive their personal
WGS data. No changes in technical knowledge of genomics were observed. Overall attitudes towards WGS were
broadly positive.
Conclusions: Providing students with intensive introductory education about WGS may help them make
informed decisions about whether or not to work with their personal WGS data in an educational setting.* Correspondence: saskia.sanderson@mssm.edu
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Whole genome sequencing inside and outside the clinic
As the technology advances and costs fall, whole gen-
ome sequencing (WGS) – the sequencing of all or
most of the DNA in the genome of an individual – is
projected to replace targeted genetic tests and single
nucleotide polymorphism (SNP) microarrays in the fu-
ture. Many laboratories already offer WGS for clinical
and research purposes. The deluge of genomic infor-
mation produced by WGS brings with it a multitude
of both opportunities and challenges in a clinical set-
ting: the opportunities include improved diagnoses,
disease treatment and prevention; the challenges in-
clude uncertainties regarding what to do with inciden-
tal or secondary findings that may arise, how to decide
what to do with variants of uncertain significance and
the extent to which patients’ preferences should be
taken into account regarding what results should be
returned. The advances in genomics are outpacing ‘un-
prepared professionals’ in the medical arena and pose
challenges to health-care providers regarding their
current ability to understand genomics data, appropri-
ately translate them into actionable results and convey
such results to patients [1].
A further consideration is that genetic testing and
sequencing are no longer restricted to clinic settings.
Although personal genomics companies have yet to
expand to WGS, personal genomics companies such
as 23andMe provide extensive personal microarray-
based genomic data and interpretations of that data to
consumers, and have provided whole exome sequen-
cing data and results to a subset of their consumers.
As a consequence, patients may already be gaining a
more direct understanding of their disease risk, dis-
ease subtypes and sensitivities to different medicines
based on their genomic information without the in-
volvement of a clinician. Although consumer genomics
is undoubtedly in a state of flux at the present time (the
Food and Drug Administration (FDA) recently ordered
23andMe to cease marketing their existing product
[2]), the FDA Commissioner recently wrote that ‘access
to tests through a direct-to-consumer model will allow
consumers to take a more active role in certain aspects
of their health’ [3], suggesting that personal genomic
information may be more widely available in the future.
Consumers can be viewed as being their own best ad-
vocates for their well-being, and many may wish to ac-
cess more genomic and other personal information
outside of a clinic and seek better understanding of
their conditions implied by these data. Medical pro-
fessionals will need to keep pace with these develop-
ments in personal genomics [1], whether the personal
genomic information is obtained inside or outside of a
clinical setting.Training medical professionals: genomics courses using
commercial personal genomics services
Advanced training is needed to help genetics profes-
sionals, and clinicians more generally, understand large
and complex datasets such as those produced by WGS.
Many institutions of higher learning are now implement-
ing advanced genomics courses to respond to this need.
Some institutions are exploring the use of novel, inter-
active and engaging approaches to replace purely didactic
lectures [4], including the use of simulators or standard-
ized patients, and internet-based genomics education for
physicians [4]. Another potential approach that has been
considered and debated is to engage health-care students
by using their own personal genomic data [5,6]. This is
based on the premise that students who engage in ‘self-
testing’ and receive personal genomic information may
benefit more from the training than students who view
the genomic information of an anonymous third party
[5,7-9] cf. [10]. While much of this is optimistic specula-
tion and debate focused on ethics rather than actual im-
plementation (one institution proposed personal genetic
testing of students but, after considerable institutional de-
liberation, ultimately opted to use aggregate genetic infor-
mation instead [6]), a handful of institutions of higher
learning have begun offering courses in which students
have the option of working with their own personal gen-
omic data. There is precedent for this in other areas of
medical training in that students often perform medical
exams on themselves and obtain personal health-related
information about themselves using a test they are learn-
ing about [1]. Yet there is currently much rigorous debate
on whether genomics courses in the educational setting
should include the option of allowing students to use their
own genomic data, and concerns about the ethics of pur-
suing this path [10-12].
Empirical data to inform this debate is urgently needed.
Despite several institutions offering personal genomic
testing within an educational setting to their students,
few have published empirical evidence regarding the stu-
dents’ experiences of these courses. Only two published
studies have reported on students’ experiences of acces-
sing their own genomic data in the classroom [12,13].
The first of these studies [12] assessed the experiences of
students on the elective GENE 210 ‘Genomics and per-
sonalized medicine’ course offered at Stanford University
School of Medicine in the summer of 2010, in which stu-
dents could obtain microarray-based genetic testing from
23andMe and Navigenics at a discounted rate, which in-
cluded common disease risk prediction, drug metabolism
and ancestry [12]. In this study, qualitative interviews
were conducted at three time points with 10 of the 46
students enrolled on the course. The results from these
interviews suggested that the students were skeptical of
some of their genomic test results, but that they found
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recalled the informed consent details, and few took up
the offered genetic counseling [12]. In the second, quan-
titative questionnaire study [13], the Stanford group
found that out of 31 students given the option of using
their own commercially produced genetic test results in
the classroom, the 23 students who opted to do so
showed significant increases in technical knowledge of
genomics, whereas the eight students who opted to use
third-party results did not, tentatively suggesting that
using personal genomic information in the classroom in-
creases learning.
Moving from receiving commercially produced genomic
test results to handling, analyzing and interpreting an
entire genome sequence
Courses such as that at Stanford are beginning to ad-
dress how biomedical professionals and students may
respond to receiving their own results from genomic
testing. However, students in the courses that use com-
mercial genomic tests do not directly engage the full
complexity of WGS data. They have little or no hands-
on experience of detecting, analyzing and interpreting
DNA variants to determine, for example, whether or not
they are of clinical significance. Current courses that rely
on consumer genomics products and test results also re-
strict attention to a fraction of the DNA variation that
exists in any individual, largely ignoring rarer variants
that may play more important roles in an individual’s
disease risk or other traits.
Given that WGS provides the complete set of inher-
ited genetic information on a person, it is reasonable to
expect that WGS will eventually become the standard in
assessing genomic variation in health care and other set-
tings in the future. It is therefore timely to explore the
implications of moving from providing students with
personal genomic test results already analyzed and inter-
preted by commercial entities to providing students with
access to their own, personal, entire WGS dataset in all
its scope and complexity. Students who work with their
own personal genomes while learning about WGS may
be more engaged with the process, more motivated to
learn about WGS, spend more time gaining the skills to
analyze and interpret their personal genome data and
appreciate more directly the impact of the testing,
decision-making and subsequent ethical, social and fa-
milial implications than if they use that of an anonymous
third party. However, there are many vital ethical and
practical questions that need to be addressed before this
practice can or should be implemented on a wide scale.
The importance of informed decision-making
Without wishing to invoke ‘genetic exceptionalism’ (the
view that genetic or genomic information is special andthat genetic and genomic tests must therefore be treated
differently and more strictly regulated than other types
of medical information [14]), a valid ethical and prag-
matic question that has not yet been tackled empirically
is whether students are capable of making independent,
informed choices or ‘informed decisions’ about whether
or not to receive their personal genome sequence, which
they may analyze and interpret as part of their genomics
training. The study of informed decision-making is re-
lated to but distinct from that of informed consent. In-
formed decision-making can be defined as a cognitive
and emotional process that leads to a decision being
made and subsequent action being carried out, based on
sufficient understanding and awareness of the risks, ben-
efits, limitations, uncertainties and alternatives regarding
the technology in question, and that is consistent with
the individual’s attitudes or views [15,16]. The concept
of informed consent in the research context similarly
includes a focus on whether individuals have sufficient
understanding on which to base their decisions, but is
more tightly tied to how that consent is obtained and
documented, and to key sets of research ethics principles
such as the Nuremberg Code (for an in-depth concep-
tual and historical review of informed consent see [17]).
While there is also a rich and thoughtful literature on
the ethics, practical considerations and challenges inher-
ent in obtaining informed consent specifically within the
personal genomics arena (see, for example, [18,19]), this
is largely outside the scope of the present report. Here,
we focus primarily on providing empirical data on the
psychological underpinnings of informed decision-making
from the students’ perspectives, albeit with a view to
informing the ongoing debates about consent and ethics
in personal genomics.
In the educational setting, there are particular con-
cerns that students may not be able to make informed,
personal choices about whether or not to receive per-
sonal genomic data as part of their genomics training
because they will feel pressured to analyze their personal
genomes, either directly or indirectly by their professors
or peers, even if this goes against their wishes. Currently,
there is no empirical data to support or refute these con-
cerns. Empirical evidence addressing whether students
are making independent, informed decisions about ana-
lyzing their own personal genomes, and whether efforts
to help students make informed decisions are successful,
would shed valuable light on a major ethical concern
surrounding personal genomes in the classroom.
One useful conceptual framework for the empirical
examination of informed decision-making is derived from
the construct of decisional conflict: decision uncertainty
or ‘decisional conflict’ is ‘a state of uncertainty about the
course of action to take’ and is ‘likely when making choices
involving risk or uncertainty of outcomes, high stakes in
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tradeoffs in selecting a course of action, and anticipated
regret over the positive aspects of rejected options’ [20]. In
this model, factors hypothesized to contribute to an indi-
vidual’s decisional conflict include lack of information,
unclear values, skill deficits in making or implementing
decisions, emotional distress and critically ‘perceived pres-
sures from important others who are imposing their
views.’ O’Connor’s Decisional Conflict Scale (DCS) [20]
was developed to assess decision uncertainty particu-
larly with a focus on the effects of informed choice
interventions, on the premise that measured reductions
in decision uncertainty may be viewed as indicators of in-
formed choice interventions being successful. The DCS
provides a useful practical measurement tool for use in
empirical research on informed decision-making in per-
sonal genomics.
The present study
With the exception of the two studies published by the
Stanford group [12,13], no other empirical data regard-
ing students’ actual experiences of obtaining personal
genomic data in an educational setting is yet available,
either regarding the downstream psychological and edu-
cational effects or the upstream issues around informed
decision-making. Moreover, no group has yet explored
the issues and potential gains to be had by having stu-
dents analyze their own entire complex WGS datasets
rather than handing students already interpreted gen-
omic results. Yet such data will be vital to efforts to de-
termine the cost-benefit ratio of incorporating personal
genomics into future educational efforts as costs of se-
quencing decline.
We therefore set out to explore student views on the
use of personal genomics in a two-part genomics course
in which students had the option to access, analyze and
interpret their own, personal, entire WGS datasets for
themselves. We were aware that this was the first time
any educational institution had enabled an entire class
of students to analyze their own personal genomes, and
so adopted a ‘first do no harm’ position with the course.
We exercised great care and caution and placed a major
focus on carrying out this study in an ethically respon-
sible way. We deliberately engaged the students in an
intensive two and a half week introductory course
(26 hours in total) over the summer of 2012 in an effort
to ensure the students had ample information on which
to base their decisions about moving forward with per-
sonal genome sequencing as part of the subsequent ad-
vanced course in the fall of 2012, in which they had the
option to access, analyze, interpret and keep their own
personal genome sequence data. The students also had
one and a half months during which to consider their de-
cision before they had blood drawn for WGS, and manysupport resources were made available to them including
genetic counselors both within and outside the institu-
tion, and access to the student mental health services.
Our overarching primary aims in this project were
twofold. First, we aimed to determine whether the intro-
ductory course successfully achieved the goal of helping
the students make more informed decisions about whether
to proceed with personal genome sequencing for educa-
tional purposes in the advanced course. Second, we aimed
to explore the educational and psychological impact of the
students having had the option of analyzing their personal,
entire genome sequence data as part of their advanced
genomics training. We also explored the students’ attitudes
towards WGS more broadly, who they discussed their
decision and personal WGS-based results with, and how
their views and understanding changed over time. Our
overarching conceptual framework for the study is shown
in (Additional file 1: Figure S1) [15,16]. In the present
paper, we present the results from the first part of the study,
that is, the part focused on informed decision-making
upstream in the process. Our specific aims here were:
Aim 1
To describe the baseline attitudes, knowledge, antici-
pated decisions and degree of informed decision-making
regarding obtaining personal WGS in an educational set-
ting, among students at the start of a two-part introduc-
tory and advanced genomics course (T1).
Aim 2
To examine whether the students’ attitudes, knowledge,
anticipated decisions and degree of informed decision-
making regarding obtaining personal WGS in an educa-
tional setting changed over time between the start and
end of the introductory genomics course (T1 to T2).
Aim 3
To examine whether the students’ attitudes, knowledge,
anticipated decisions and degree of informed decision-
making regarding obtaining personal WGS in an educa-
tional setting changed over time between the end of the
introductory and start of the advanced genomics course
(T2 to T3), and who the students had discussed their
decision with at T3. We also report the proportion of
students who opted to analyze their own versus a third-
party genome after T3.
We hypothesized that this self-selected group of stu-
dents would express positive attitudes towards WGS
generally and WGS in an educational context specific-
ally, and considerable interest in having their own ge-
nomes sequenced, but that their knowledge would be
low, when they started the introductory course at base-
line (T1). We also hypothesized that their knowledge
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introductory course, that their attitudes would become
less positive as they learned more about the risks, limita-
tions and uncertainties surrounding WGS technology
during the introductory course and that their interest in
having their own genomes sequenced would also conse-
quently wane, but that they would feel they were making
significantly more informed choices by the end com-
pared to the start of the introductory course (T1 to T2).
Finally, we hypothesized that few changes in attitudes,
knowledge or interest would be observed between the
end of the introductory course and start of the advanced
course (T2 to T3). By collecting and comparing data at
all three time points (T1, T2 and T3), the study design
allowed us to explore whether greater changes were ob-
served in response to the introductory course (that is,
between the start and end of the first course, T1 to T2)
than might reasonably have been expected simply due to
time passing (indicated by the time passing between the
end of the first course and the start of the second
course, T2 to T3). For completeness and to see whether
improvements in informed decision variables were main-
tained, we also compared responses between the start of
the introductory and the start of the advanced courses
(T1 to T3). In the present article, we report the results
from analyses in which we assessed whether the students
made informed decisions, and whether their decisions
appeared to be more informed as a consequence of hav-
ing engaged in the introductory course. We also report
the students’ attitudes towards WGS more broadly and
who they discussed their decision with.
Methods
Study design and procedure
This was a longitudinal cohort study of students en-
rolled in a two-part introductory and advanced genom-
ics course at the Icahn School of Medicine at Mount
Sinai (ISMMS), New York. The introductory course,
‘Introduction to human genome sequencing’, was of-
fered in July and August 2012, and the advanced course,
‘Practical analysis of your personal genome’, was offered
in the fall semester of 2012. Students completed ques-
tionnaires about a range of topics including their atti-
tudes towards the use of personal genomes in the
educational setting before and after each course (see
Additional file 2: Figure S2 for a participant flow chart).
Through the use of the surveys we attempted to engage
the students in the decision-making process about in-
corporating personal genomes into a genome-sequencing
course, and collect input on those factors that had the
potential to help or hinder the process. Student views pre-
sented in this article were assessed via three paper ques-
tionnaire surveys, one before and after the introductory
course (see Additional file 3 for the first questionnaire) andone before the advanced course (see Additional file 4 for
the second questionnaire). See Additional file 5: Table S1
for an overview of all the data collection time points in this
study and the measures assessed at each time point.
The course and research study were developed by a
multidisciplinary group of experts in genetic counsel-
ling, medical genetics, health psychology and bioinfor-
matics. The aim of the introductory genomics course,
‘Introduction to human genome sequencing’, was to pro-
vide the genomic, computing and algorithm fundamen-
tals required to assemble, analyze and interpret WGS
data, and appreciation of the potential risks and benefits
and the ethical and psychological issues that could be
raised (see Additional file 6 for the introductory course
syllabus). During this course, students were also informed
that when examining their WGS data during the advanced
course, they could exclude data they did not wish to see.
This course was a prerequisite for the advanced genomics
course. The advanced genomics course, ‘Practical ana-
lysis of your personal genome’, was developed with the aim
of providing students with the skills to analyze WGS data,
and to carry out a variety of interpretations on these ana-
lysis results, including general assessments of genome-
wide small nucleotide variations, identification of carrier
status for variants of known medical significance, charac-
terization of risks of different diseases and identification
of high-impact mutations of unknown medical significance
(see Additional file 6 for advanced course syllabus).
Throughout the advanced course, students were given the
option of analyzing and interpreting either their own
WGS data or that of an anonymous donor. Funds for con-
ducting the sequencing were provided by the ISMMS
Institute for Genomics and Multiscale Biology, and the
personal genome sequence data were provided to the
students free of charge.
Medical students, genetic counseling students, resi-
dents and fellows who might use the information in
their practice or research and PhD students who might
apply the information to their research were the target
group for the course. The introductory course was ad-
vertised as a prerequisite course for the advanced human
genome sequencing course in which students could have
their own genomes sequenced at no cost to them with in-
structors blind to their decision to do so or not. Students
who completed the introductory course were eligible to
enroll on the advanced course and to take part in the re-
search. The research information sheets provided to the
students can be found in Additional files 7, 8 and 9. Fur-
ther methodological detail can be found in Additional
file 10: Supplementary Methods.
All of the 20 students who started the course were re-
cruited to complete the questionnaires at the outset of
the study, and all completed the questionnaires before
and after the introductory course. Nineteen of the twenty
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unable to attend the mandatory first class of the advanced
course and so could not be enrolled). Of the 19 students
who were enrolled in the advanced course, all completed
the survey at the start of the advanced course. The final
sample size for the present study was therefore N = 19. Five
were genetic counseling masters students, three were med-
ical genetics residents, three were MD/PhD students, three
were PhD students, two were medical students, two were
junior faculty and one was a genetics fellow. Both clinical
faculty members used genetics regularly in their work and
most but not all of the MD and PhD students had had
some prior experience with molecular genetics or genom-
ics in a research context. Ten of the students were male,
nine were female.
This research conformed to the Declaration of Helsinki.
The dean, the Research Ethics Committee (a separate
body to the Institution Review Board (IRB)), which
reviews issues that fall outside the remit of the IRB, and
the CePORTED (Center for Patient Oriented Research,
Training, Education and Development) curriculum com-
mittee at ISMMS all approved the study and/or the
course. The study was submitted to the IRB, which deter-
mined that the sequencing was part of the educational ex-
perience and that the research component of the proposal
(questionnaires) posed no greater than minimal risk and
met criteria for exemption under Category 2 Research in-
volving the use of educational tests or survey procedures.
In addition, the course directors consulted the ISMMS
general counsel and the Division of Genetics at the New
York State Department of Health.
Measures
As described in Additional file 5: Table S1 and the supple-
mental methods (Additional file 10), the major classes of
primary variables that were assessed in the questionnaires
at time points T1, T2 and T3 were: students interest in
analyzing their own genome in an educational setting, in-
cluding intentions, decision and discussion of decision with
others; informed decision-making (this was assessed using
O’Connor’s 2005 Decisional Conflict Scale and five sub-
scales: the informed subscale, the effective decision-making
(satisfaction) subscale, the support subscale, the values
clarity subscale and the uncertainty subscale); attitudes to-
wards WGS in an educational setting; attitudes towards
WGS in general and knowledge regarding how to interpret
DNA variants associated with disease risk in a clinical set-
ting. We also present and describe the open-ended com-
ments students provided at the end of the questionnaires
at each of the three time points.
Statistical analyses
We used Kolmogorov–Smirnov tests to determine that
interest, decision, decisional conflict individual items,attitudes towards WGS in an educational setting and atti-
tudes towards WGS in general were non-normally distrib-
uted. The tests showed that decisional conflict scale and
subscales results were normally distributed.
The first ‘interest’ item (which assessed interest in ana-
lyzing their own genome with six response options) was
recoded so that the ‘don’t know’ and ‘it depends’ response
options were recoded into the midpoint. The scores
were therefore: 1 = no, definitely not, 2 = no, probably
not, 3 = don’t know/it depends, 4 = yes, probably, 5 = yes,
definitely. This was done so that the variable could be
treated as a continuous variable without discarding the
‘don’t know’ and ‘it depends’ response options. We de-
scribed the variable at each time point (T1, T2 and T3)
using frequencies, then conducted a non-parametric
test to examine changes over time between T1 to T2,
T1 to T3 and T2 to T3 because of the clearly highly
skewed distribution of this variable at each time point.
We used the Wilcoxon signed-rank test because the re-
sults were two non-parametric sets of scores from the
same participants. We calculated the effect size r in
Excel using the following equation in accordance with
Field [21] (p. 550):
r ¼ Z  √N
For the ‘decision’ variable, we ran frequencies to observe
and report how many respondents opted for Option 1
(analyze own genome), how many opted for Option 2
(analyze an anonymous genome) and how many did not
respond to this question. We then recoded the variable so
that the missing data points were recoded into Option 2
(analyze other genome). We then conducted a non-
parametric test (Wilcoxon signed-rank test) as the vari-
able was clearly skewed. Effect sizes were calculated as
above. We also reported the median for this and all other
items apart from the knowledge items. The 15 individual
items of the decisional conflict scale (DCS) were also
non-normally distributed and so were analyzed using the
Wilcoxon signed-rank test as above. Effect sizes were also
calculated as above.
The DCS scale and subscale were normally distributed
and so changes over time on these measures were assessed
using paired samples t-tests. The effect sizes were calcu-
lated in Excel using the following equation (Rosenthal [22])
in accordance with Field [21] (p. 332):
r ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
t2  t2 þ dfð Þð Þ
q
Attitudes towards WGS in an educational setting were
non-normally distributed and so were analyzed using the
Wilcoxon signed-rank test as above. Effect sizes were
also calculated as previously. Attitudes towards WGS in
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analyzed using Wilcoxon signed-rank tests with effect
sizes calculated as above. Knowledge items were dichot-
omous and were analyzed using Wilcoxon signed-rank
tests with effect sizes calculated as above.
Effect sizes were described according to Cohen’s criteria
of .3 and .5 for a medium and large effect, respectively
(Field [21], p. 558). All tests were two-tailed and signifi-
cance values were P < 0.05. All statistical analyses were
conducted using IBM SPSS version 19 (Chicago, IL), with
the exception of the effect sizes which were calculated
using Excel 2010.
Results
Aim 1: To assess key whole genome sequencing
decision-related attitudes and knowledge at the start of
an introductory genomics course (T1)
Interest and decision
At baseline, 17 of the 19 students selected ‘Option 1: I
would like to analyze my own genome as part of an ad-
vanced WGS course’, while the remaining two students
selected ‘Option 2: I would not like to analyze my own
genome as part of an advanced WGS course, and would
rather analyze an anonymous donated genome’ (see
Table 1). Similarly, 17 of the 19 students said that they
would ‘probably’ or ‘definitely’ want to analyze their own
genomes as part of the advanced WGS course when pre-
sented with six response options ranging from ‘no, defin-
itely not’ to ‘yes, definitely.’ However, it is worth noting
that the median response was ‘yes, probably’ and that
only seven students selected ‘yes, definitely’ at this time
point (see time point T1 in Figure 1).
Decisional conflict (scale and subscales)
At baseline, the mean overall decisional conflict scale
score was 33.9 ± 18.2 (range 0.0 to 70.3). This was lower
than the cut-off of 37.5 (scores exceeding 37.5 are asso-
ciated with decision delay or feeling unsure about imple-
mentation), but exceeded the cut-off of 25 (scores lower
than 25 are associated with implementing decisions),
suggesting that the students were experiencing some
conflict around their decision regarding whether or not
to have their genomes sequenced as part of the advanced
WGS course. The mean scores for all five decisional
conflict subscales similarly exceeded 25 at baseline (see
Table 1 and Time point 1 in Figure 2).
Decisional conflict (individual items)
As Figure 3A shows, only 47% of the students stated
that they were making an ‘informed choice’ at base-
line. Relatedly, only 47% felt they knew the risks of
each option, only 42% felt that the decision was easy
for them to make and only 53% felt they had enough
advice to make a choice. Further, 68% stated that theyknew the benefits of each option. Of the students, 95%
(18 out of the 19) stated that they were ‘choosing without
pressure from others’ (see time point T1 in Figures 3B–F;
also see Table 1).
Attitudes towards whole genome sequencing in an
educational setting
At baseline, 16 of the 19 students believed that analyzing
their own genomes as part of the advanced WGS course
‘would be useful’, and all 19 of the students agreed or
strongly agreed that an important reason in favor of
using their own genome was to ‘satisfy general curiosity’.
The students endorsed a number of additional reasons
for wanting to analyze their own genomes, including de-
termining if specific diseases run in their family or are
DNA based, helping understand principles of human
genetics and enhancing their understanding of what a
patient may learn or experience by having their genomes
sequenced (see Additional file 5: Table S2). Sixteen stu-
dents agreed or strongly agreed that they would see this
as an opportunity to get a service that they would not
ordinarily get if they had to pay full price. Only two stu-
dents stated that they would be concerned that their
professors ‘would know who took up the offer of testing
and who did not’. Some additional concerns were en-
dorsed, with ten students expressing concern about privacy
or risks to privacy, and 15 students expressing concern
that they might get some results that would be disturbing.
See Additional file 5: Table S2 for the complete results re-
garding attitudes towards WGS in an educational setting
at baseline.
Attitudes towards whole genome sequencing in general
Students had wide-ranging general views regarding WGS
(see Additional file 5: Table S3). For example, a majority of
the students felt that results of WGS would influence
health-care decisions, but none of the students agreed that
‘most people can accurately interpret WGS results’. Fewer
than half agreed that WGS results would be useful to a
physician. In line with the decisional conflict items, only 11
of the 19 students reported that they understood the risks
and benefits of getting personal WGS done (see Additional
file 5: Table S3).
Knowledge
Fewer than half of the students correctly interpreted the
information provided in the clinical scenarios that were
used to assess knowledge, indicating low levels of know-
ledge at baseline (Additional file 5: Table S4). Scores
were similarly low on the other knowledge measures
assessing what factors influenced their understanding
and how they would counsel a patient (Additional file 5:
Table S4).
Table 1 Students’ interest in analyzing their own genomes in an educational setting
N = 19 Response options T1 T2 T3 Significancec
Interest/decision N (%) N (%) N (%) T1 to T2a T1 to T3a T2 to T3a
Would you want to analyze your
own genome as part of an
advanced WGS course?
No, definitely not 0 (0%) 0 (0%) 0 (0%) z = −1.41, P = 0.16,
r = −0.32
z = −2.46, P = 0.014,
r = −0.56
z =−2.24, P= 0.025,
r = −0.51
No, probably not 2 (10.5%) 0 (0%) 0 (0%)
Don’t know/It depends 0 (0%) 2 (10.5%) 0 (0%)
Yes, probably 10 (52.6%) 7 (36.8%) 6 (31.6%)
Yes, definitely 7 (36.8%) 10 (52.6%) 13 (68.4%)
Median Yes, probably Yes, definitely Yes, definitely
At this point, which of the following
options would you prefer? Please
check one.
Option 1: I would like to analyze
my own genome as part of an
advanced WGS course.
17 (89.5%) 18 (94.7%) 18 (94.7%) z = −1.41, P = 0.16,
r = −0.32
z = −0.58, P = 0.56,
r = −0.13
z = −1.00, P = 0.32,
r = −0.23
Option 2: I would not like to
analyze my own genome as
part of an advanced WGS course,
and would rather analyze an
anonymous donated genome.
2 (10.5%) 0 (0%) 0 (0%)
[Participant did not check
either option]
0 (0%) 1 (5.3%) 1 (5.3%)
Decisional conflict: individual items (agree/strongly agree) N (%) N (%) N (%) T1 to T2a T1 to T3a T2 to T3a
I know which options are available to me. 17 (89.5%) 19 (100%) 18 (94.7%) z = −1.90, P = 0.058,
r = −0.44
z = −2.45, P = 0.014,
r = −0.56
z = 0.00, P = 0.99,
r = 0.00
Median Agree Strongly agree Strongly agree
I know the benefits of each option. 13 (68.4%) 18 (94.7%) 18 (94.7%) z = −2.57, P = 0.010,
r = −0.59
z = −3.00, P = 0.003,
r = −0.69
z =−2.00, P= 0.046,
r = −0.46
Median Agree Agree Strongly agree
I know the risks of each option. 9 (47.4%) 17 (89.5%) 18 (94.7%) z = −2.86, P = 0.004,
r = −0.66
z = −3.41, P = 0.001,
r = −0.78
z = −1.34, P = 0.18,
r = 0.31
Median Neither Agree Agree
I am clear about which benefits matter most to me. 10 (55.6%) 16 (84.2%) 18 (94.7%) z = −2.51, P = 0.012,
r = −0.58
z = −2.80, P = 0.005,
r = −0.64
z = −0.38, P = 0.71,
r = −0.08
Median Agree Agree Agree
I am clear about which risks matter most. 9 (47.4%) 16 (84.2%) 17 (89.5%) z = −2.41, P = 0.016,
r = −0.55
z = −2.38, P = 0.017,
r = −0.55
z = −0.07, P = 0.94,
r = −0.02
Median Neither Agree Agree
I am clear about which is more important to me
(the benefits or the risks).
11 (57.9%) 16 (84.2%) 17 (89.5%) z = −1.51, P = 0.13,
r = −0.35
z = −2.23, P = 0.026,
r = −0.53
z = −1.67, P = 0.096,
r = 0.38
Median Agree Agree Agree
I have enough support from others to make a choice. 10 (52.6%) 18 (94.7%) 15 (78.9%) z = −2.88, P = 0.004,
r = −0.66
z = −2.12, P = 0.034,
r = −0.49
z = −0.92, P = 0.36,
r = −0.21
Median Agree Agree Agree
I am choosing without pressure from others. 18 (94.7%) 17 (89.5%) 17 (89.5%) z = −0.63, P = 0.53,
r = −0.14
z = −0.82, P = 0.41,
r = 2.25
z = 0.00, P = 0.99,
r = 0.00

















Table 1 Students’ interest in analyzing their own genomes in an educational setting (Continued)
I have enough advice to make a choice. 10 (52.6%) 14 (73.7%) 17 (89.5%) z = −2.44, P = 0.015,
r = −0.56
z = −3.09, P = 0.002,
r = −0.71
z = −1.73, P = 0.083,
r = −0.40
Median Agree Agree Agree
I feel sure about what to choose. 11 (57.9%) 13 (68.4%) 15 (78.9%) z = −1.21, P = 0.23,
r = −0.28
z = −1.96, P = 0.051,
r = 0.45
z = −1.16, P = 0.25,
r = −0.27
Median Agree Agree Agree
This decision is easy for me to make. 8 (42.1%) 12 (63.2%) 13 (68.4%) z = −1.73, P = 0.083,
r = −0.40
z = −2.51, P = 0.012,
r = 4.36
z = −1.40, P = 0.16,
r = −0.32
Median Neither Agree Agree
I feel I have made an informed choice. 9 (47.4%) 16 (84.2%) 19 (100%) z = −2.88, P = 0.004,
r = −0.66
z = −2.97, P = 0.003,
r = −0.68
z = −1.13, P = 0.26,
r = −0.26
Median Neither Agree Agree
My decision shows what is important to me. 12 (63.2%) 18 (94.7%) 15 (78.9%) z = −2.39, P = 0.017,
r = −0.55
z = −2.33, P = 0.020,
r = 4.36
z = −0.38, P = 0.71,
r = 0.08
Median Agree Agree Agree
I expect to stick with my decision. 14 (73.7%) 15 (78.9%) 17 (89.5%) z = −0.92, P = 0.36,
r = −0.21
z = −2.17, P = 0.030,
r = 0.50
z = −1.13, P = 0.26,
r = −0.26
Median Agree Agree Strongly agree
I am satisfied with my decision. 12 (63.2%) 15 (78.9%) 17 (89.5%) z = −2.65, P = 0.008,
r = −0.61
z = −2.71, P = 0.007,
r = 0.62
z = −1.00, P = 0.32,
r = −0.23
Median Agree Agree Agree






T1 to T2b T1 to T3b T2 to T3b






t(18) = 3.99, P = 0.001,
r = 0.69
t(18) = 4.83, P< 0.001,
r = 0.75
t(18) = 1.72, P = 0.10,
r = 0.38
Subscales:






t(18) = 3.66, P = 0.002,
r = 0.65
t(18) = 4.88, P< 0.001,
r = 0.75
t(18) = 1.79, P = 0.090,
r = 0.39






t(18) = 3.78, P = 0.001,
r = 0.67
t(18) = 4.00, P= 0.001,
r = 0.69
t(18) = 1.18, P = 0.25,
r = 0.27






t(18) = 3.43, P = 0.003,
r = 0.63
t(18) = 3.36, P= 0.003,
r = 0.62
t(18) = 0.36, P = 0.73,
r = 0.08






t(18) = 2.79, P = 0.012,
r = 0.55
t(18) = 3.23, P= 0.005,
r = 0.61
t(18) = 0.94, P = 0.36,
r = 0.22






t(18) = 1.95, P = 0.067,
r = 0.42
t(18) = 3.13, P= 0.006,
r = 0.59
t(18) = 1.57, P = 0.13,
r = 0.35
aDifferences assessed using Wilcoxon signed-rank test.
bDifferences assessed using paired samples t-tests.

















Figure 1 Trend relating to desire to analyze one’s personal genome in an advanced genome sequencing course. This was observed at
three time points before an introductory genomics course (T1), after the introductory genomics course (T2) and before the subsequent advanced
genomics course (T3) taken by 19 students at the Icahn School of Medicine at Mount Sinai during the 2012 summer and fall semesters. Desire to
analyze their own genome did not change between T1 and T2 (Wilcoxon signed-rank test P = 0.16), but significantly increased between T1 and
T3 (Wilcoxon signed-rank test P = 0.014), and between T2 and T3 (Wilcoxon signed-rank test P = 0.025).
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attitudes and knowledge between the start and end of an
introductory genomics course (T1 to T2)
Interest and decision
At the end of the introductory course, ten students stated
that they would ‘definitely’ like to analyze their own ge-
nomes, compared to the seven students who stated this
at baseline. This was not a statistically significant change,
although it is worth noting that this was nonetheless
a medium effect size (z = −1.41, P = 0.16, r = 0.32). See
Table 1 for the full interest/decision results.
Decisional conflict (scale and subscales)
There was a significant decrease between baseline and the
end of the introductory course (T1 to T2) in decisional
conflict overall, and the effect size was large (t(20) = 3.66,
P = 0.002, r = 0.69). Similarly, there were significant
changes between T1 and T2 on four of the five decisional
conflict subscales, all with large effect sizes with r > 0.5, in-
dicating that the students felt significantly more informed,
more satisfied and more supported and had greater clarity
about their values after compared to before the introduc-
tory course (see Figure 2). There was also a medium effect
size for the uncertainty subscale, although this did not
reach statistical significance (see Table 1).
Decisional conflict (individual items)
Also as shown in Table 1, examination of the individual
decisional conflict items revealed that there were several
significant shifts between T1 and T2. For example, the
proportion of students who stated they were making ‘aninformed choice’ increased from 47% at the start of the
introductory course to 84% at the end of the introduc-
tory course (z = −2.88, P = 0.004, r = −0.66). Similarly, the
proportion who stated that they knew ‘the risks’ in-
creased from 47% to 90% (z = −2.86, P = 0.004, r = −0.66)
(see also Figure 3).
Attitudes towards whole genome sequencing in an
educational setting
The students’ attitudes towards WGS in an educational
setting mainly did not change significantly during the
introductory course. However, there were a few notable
exceptions. By the end of the introductory course,
fewer students were concerned about privacy (z = −2.39,
P = 0.017, r = 0.55) and fewer were concerned that people
would find out genetic or health information about them
(z = −2.49, P = 0.013, r = 0.57). Also, a greater number of
students believed that their own results would help them
understand genetic concepts better than someone else’s re-
sults (z = −2.12, P = 0.034, r = 0.49). (See Additional file 5:
Table S2).
Attitudes towards whole genome sequencing in general
As shown in (Additional file 5: Table S3), the students’
attitudes towards WGS in general also did not change
significantly during the introductory course, with the
exception that significantly more students felt that they
understood the risks and benefits of personal genome
sequencing by the end of the course (z = −2.71, P = 0.007,
r = 0.62). The observed changes were largely maintained
over time, in that the differences remained significant in
Figure 2 Trends relating to decisional conflict overall scale and five subscales about using one’s personal genome in an advanced
genome sequencing course. These were observed as part of a two-part genomics course taken by 19 students at the Icahn School of Medicine
at Mount Sinai in 2012. All P values were calculated using paired samples t-tests. Lower scores indicate lower levels of decisional conflict. Scores
are means with standard error bars displayed. (A) Decisional conflict about whether or not to get one’s own genome sequenced decreased over
time between T1 and T2 (P < 0.001) and T1 and T3 (P < 0.001). The difference was not significant between T2 and T3 (P = 0.10). (B) Scores on the
informed subscale decreased between T1 and T2 (P = 0.002) and between T1 and T3 (P < 0.001) indicating students felt more informed at T2 and
T3 than they did at T1. (C) Scores on the effective decision-making subscale decreased between T1 and T2 (P = 0.001) and between T1 and T3
(P = 0.001), indicating students felt more satisfied with their decisions at T2 and T3 than they did at T1. (D) Scores on the support subscale decreased
between T1 and T2 (P = 0.003) and between T1 and T3 (P = 0.003), indicating students felt more supported at T2 and T3 than they did at T1. (E) Scores
on the values clarity subscale decreased between T1 and T2 (P = 0.012) and between T1 and T3 (P = 0.005), indicating students felt greater clarity about
their values at T2 and T3 than they did at T1. (F) Scores on the uncertainty subscale decreased between T1 and T3 (P = 0.006), indicating students felt
less uncertainty about their decisions at T3 than they did at T1.
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course with the start of the advanced course (T1 to T3; see
Additional file 5: Table S3).
Knowledge
Knowledge regarding interpretation of clinically presented
genomic test results did not change from before to after
the introductory course (see Additional file 5: Table S4).
Aim 3: To assess changes over time in key decision-related
attitudes and knowledge between the end of an
introductory course and start of an advanced genomics
course (T2 to T3)
As shown in Table 1, Additional file 5: Tables S2, S3 and
S4, and Figures 2 and 3, there were few changes over
time between the end of the introductory and start of
the advanced genomics course (T2 to T3). When asked
with whom they had discussed their decision aboutwhether to get their genome sequenced, 12 students
stated they had discussed the decision with their friends,
ten with their spouse or significant other, eight with their
mother and two with a genetic counselor (see Table 2). All
of the students stated that they ‘probably’ or ‘definitely’
intended to have blood drawn for genome sequencing and
to analyze their genome sequence as part of the ad-
vanced course. Seven students stated that they ‘probably’
or ‘definitely’ were going to talk to a genetic counselor
about their decision. Based on the course records, all 19 of
the students subsequently chose to have blood drawn and
analyze their own genome data as part of the advanced
course, and only two students talked to a genetic counselor
prior to making this decision (see Table 2).
Students’ responses to open-ended comments section
Here we briefly describe the students’ responses to the
open-ended comments sections at the end of each of the
Figure 3 Trends relating to decisional conflict individual items. (A) I feel I have made an informed choice. (B) I am choosing without
pressure from others. (C) I have enough advice to make a choice. (D) I know the risks of each option. (E) I know the benefits of each option.
(F) This decision is easy for me to make.
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http://genomemedicine.com/content/5/12/113three questionnaires, focusing particularly on responses
related to the students’ views on personal WGS.
At the beginning of the introductory course (T1),
students’ responses to the open-ended comments sec-
tion of the questionnaire reflected two main themes: con-
cerns about personal WGS (expressed by four students)
and questions about personal WGS (expressed by three
students). The concerns largely mapped onto those listed
in the quantitative part of the questionnaire, and included
concerns about treatments or cures for many genetic
diseases being unavailable, privacy and who would have
access to the WGS results and implications for life insur-
ance. One student particularly expressed fear of detecting
predisposition to disease, while another thought that ana-
lyzing their own genome might not be more educational
and could be disturbing. Specific questions raised included
whether genetic counselling would be available before or
after personal WGS, whether course directors would know
the results of personal WGS and whether an information
letter would be provided for family members.
At the end of the introductory course (T2), some
students again raised concerns about personal WGS
(three students in total), including concerns about priv-
acy and ownership of data. One student in particular
stated that the decision to sequence their own genome or
not remained very difficult for them due to many variants
being difficult to interpret, and because they remainedfearful of finding variants that carried significant disease
risk. One student stated that they thought a ‘mock’ gen-
ome would be just as useful to their learning experience.
Two students expressed excitement about getting their
own genomes sequenced. Whereas a number of ques-
tions had been raised about personal WGS at the start of
the course, only one student raised questions at the end
of the course, and these related to privacy, ownership of
genomic information and publication or access to the
genomic information by third parties. Several students
expressed positive views of the introductory course.
At the start of the advanced course (T3), no concerns
were expressed or questions raised in this section of the
questionnaire. See Additional file 5: Table S5 for all of
the students’ responses to the open-ended questionnaire
sections.
Discussion
The results of our study suggest that students enrolled
in an introductory WGS course were interested in ana-
lyzing their own genomes. This interest did not appear
to be affected by learning more about the risks and limi-
tations of WGS and the course successfully reduced the
degree of uncertainty students felt about their decision
whether or not to sequence their own genomes. As a
result of the introductory genomics course, it appears
that the majority of the students made more informed
Table 2 Discussion of the decision with others and intentions at T3, and actual decisions made subsequently
N = 19 N (%)
Discussion of decision with others, self-reported at T3
Have you discussed whether or not to get your genome sequenced
as part of this course with anyone?
Yes 17 (89.5%)
No 2 (10.5%)
Who have you talked to about whether or not to get your genome
sequenced as part of this course?
Genetic counselor 2 (10.5%)




Other family member 3 (15.8%)
Friend(s) 12 (63.2%)
Spouse/significant other 10 (52.6%)
One or more of the course directors 1 (5.3%)
Other (if other, please specify)a 1 (5.3%)
Intentions, self-reported at T3
I intend to have the blood draw for WGS as part of this course No, definitely not 0 (0%)
No, probably not 0 (0%)
Don’t know/it depends 0 (0%)
Yes, probably 6 (31.6%)
Yes, definitely 13 (68.4%)
Median Yes, definitely
I intend to analyze my own genome as part of this WGS course No, definitely not 0 (0%)
No, probably not 0 (0%)
Don’t know/it depends 0 (0%)
Yes, probably 6 (31.6%)
Yes, definitely 13 (68.4%)
Median Yes, definitely
I intend to seek genetic counseling before making my decision about
whether to obtain my own personal genome sequence data
No, definitely not 5 (26.3%)
No, probably not 7 (36.8%)
Don’t know/it depends 0 (0%)
Yes, probably 2 (10.5%)
Yes, definitely 5 (26.3%)
Median No, probably not
Observed actual behaviors, after T3
Did the student actually have their blood drawn and analyze their own
genome as part of the WGS course?
Yes 19 (100%)
Did the student see the genetic counselor provided within the medical
school prior to receiving their WGS data?
Yes 2 (10.5%)
Did the student see the genetic counselor provided outside of the medical
school prior to receiving their WGS data?
Yes 0 (0%)
aThe ‘other’ response here was: ‘Just mentioned it not looking for an answer because there is actually no question here. I will meet with a genetic counselor
though just to learn about the experience’.
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average they felt more informed, more clear about their
personal values regarding benefits and risks, more sup-
ported in their decision-making and more satisfied with
their decision after, compared to before, the course. This
suggests that the introductory course improved the extent
to which students were able to make informed decisions
about getting their genomes sequenced and they were de-
cisions that they were comfortable with.
Although the course made students feel that they were
making a more informed decision as measured by
the variables in the Decisional Conflict Scale, when we
attempted to measure objectively whether knowledge
about genomics concepts increased from pre- to post-
course we found no significant changes over time. This
could be because we utilized a set of three scenario-
based questions that were developed by the group at
Stanford [23] and which therefore focused more on un-
derstanding and interpretation of consumer genomics
test results, rather than being developed specifically to
tap acquired knowledge about the topics covered in our
WGS course. Measuring knowledge about genomics is
notoriously difficult, and there were few alternative
existing measures at the time that we could have used.
Although one new measure has now been developed
for use with general populations [24], it is not clear that
this measure would be appropriate for use with stu-
dents learning about WGS at a higher level. Further
validation of the measure by Kaphingst and colleagues
in different populations is needed, and new measures of
knowledge about WGS that can be used with students
of genomics need to be developed. It may also be argued
that objectively assessed knowledge about genomics
and WGS is not an essential prerequisite for informed
decision-making about personal genome sequencing, and
that feeling informed about the risks and benefits is more
important in this context.
In all areas of life, what people say they will do does
not always map on to what they actually subsequently
do. This is as true in personal genomics and genetic test-
ing as anywhere else. When surveyed, a majority of indi-
viduals say that they are interested and would obtain
personal genetic or genomic information about them-
selves if given the opportunity [25-30], yet invariably,
fewer individuals actually go on to have genomic or gen-
etic testing when it really is presented to them as an op-
tion [26,27,29]. This diminished interest in the face of
making an actual decision may be attributable to the in-
dividual learning more about the risks, limitations and
uncertainties of the technology, and thinking through
more carefully what the actual psychosocial, financial
and other potentially adverse outcomes might be for them
personally, as well as practical barriers. Often, genetic
counseling is a key facilitator of this more deliberativeprocess. In an educational context, students who opt to
take courses in which they are given the option of obtain-
ing personal genomic information free of charge are likely
to be a highly self-selected sample with considerable inter-
est in getting their genomes sequenced at baseline. How-
ever, previous evidence from other contexts suggests that
even individuals who are initially interested in receiving
personal genetic or genomic information often lose interest
when they learn more about the risks and limitations or
think through the implications for them personally more
carefully. In a survey of students attending a genomics
course (in which personal genomic data was not offered) at
Stanford University, the students expressed considerable
enthusiasm for personal genomics, but their enthusiasm
decreased over time as they learnt more during the course
[23]. This emphasizes the likely importance of providing
students with sufficient information, time and support to
make considered and informed personal decisions about
whether to get their genomes sequenced as part of their
educational process.
In the present study, our findings do indeed suggest
that providing information, time and support may be
important in helping students make informed decisions
about receiving their personal genome sequence data as
part of their education. However, it is also important to
note that the students in our study were offered their
personal genome sequence data free of charge. This dif-
fers from the Stanford study in which students paid to-
wards their 23andMe genetic test results [12,13]. The
fact that the students on our course were offered some-
thing that is not widely available – their entire personal
genome sequence – at no financial cost to them, could
have had a considerable impact on how they weighed
the benefits vs. risks of receiving, and on their ultimate
decisions to receive, their personal genomes. This is sup-
ported by our finding that most students agreed with
the statement that getting WGS in an educational set-
ting would be ‘an opportunity that I would not ordinarily
get if I had to pay full price’. The fact that the students
in our study were able to obtain and keep their personal
genome sequence data at no financial cost to them,
could clearly have been a significant incentive to them
to participate and have their genomes sequenced, per-
haps trumping even significant concerns or worries
about risks that they might have been feeling.
The primary limitations of our study included that this
was a single site study with a small sample size, and that
due to the preliminary nature of the study we did not
correct for multiple comparisons in the statistical ana-
lyses. The small number of individuals included in the
study could clearly leave us underpowered to detect dif-
ferences that we would have otherwise detected had we
had a larger sample size. However, it was arguably ap-
propriate to conduct this first-of-a-kind study on a small
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ing more likely to be alerted to problems than if there
were a larger number of students involved), before con-
sidering scaling up with a larger number of students.
Perhaps more important is the self-selected nature of
this group of students. Some responded to an email ad-
vertising the course, and some were informed about the
course because they were either within or connected to
the Department of Genetics and Genomic Sciences.
These students may very likely have had greater enthusi-
asm for personal genome sequencing, both by nature of
being self-selected on to the course, and because of the
novelty of the course at the time it was offered, than
other students in other contexts are likely to have in the
future. The results are therefore not generalizable to other
students, and would need to be replicated in samples of
students with differing characteristics, for example, at dif-
ferent sites and from different disciplinary backgrounds,
before general conclusions could be drawn.
We recognize that there could have been some under-
reporting of some variables, for example, whether the
students felt pressured by others or felt unable to be
critical of the course out of concern for how this might
affect their assessment by the course directors or their
interactions with their peers. In addition, because there
was no control group, we cannot directly infer causality.
The changes over time could conceivably have occurred
due to factors outside the context of the course. How-
ever, due to the study design, we were able to compare
changes over time before and after the introductory
course to changes over time in which students were not
attending genomics classes: the results suggested that it
was the content of the course that successfully increased
the extent to which the students felt they were making
informed decisions about whether or not to analyze their
own genomes, rather than simply the passing of time.
Conducting this study or one like it with a control group
would certainly further reduce the potential for con-
founding factors to play a role, although this would be
challenging within an educational setting.
Finally, it is not clear whether 26 hours of teaching
prior to decision-making is necessary, or whether fewer
hours would lead to similar shifts in informed decision-
making. However, despite the limitations and continuing
concerns regarding ethical and legal issues, our study
provides a framework for others to carry out studies on
personal genome use in medical genomic courses, and
suggests that significant efforts to increase informed
decision-making among students are worthwhile.
Conclusions
In the present study, we examined informed decision-
making and related outcomes among students who were
considering having their genomes sequenced as part of anovel WGS course. There are concerns, both practical
and ethical, about enabling students to analyze their
own personal genomes for educational purposes if they
so choose. The results of our study provide empirical
evidence to inform the debate on this issue and suggest
that the majority of students on this WGS course were
able to make independent, informed choices. Most of
these students did not feel pressured into using their
own genomes, and were comfortable with their deci-
sions. While recognizing the limitations of this small
study, we conclude that, given appropriate levels of sup-
port, information and time, the majority of students are
likely to make informed choices about having their per-
sonal genomes sequenced.
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